Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

ICON plc – Ordinary Shares (ICLR): Insiders Aren’t Crazy About It

Page 1 of 2

ICON plc – Ordinary Shares (NASDAQ:ICLR) has experienced an increase in hedge fund sentiment in recent months.

To the average investor, there are dozens of metrics investors can use to watch stocks. A pair of the best are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite hedge fund managers can outperform the market by a healthy amount (see just how much).

ICON plc - Ordinary Shares (NASDAQ:ICLR)

Equally as key, positive insider trading activity is another way to parse down the investments you’re interested in. Obviously, there are a variety of motivations for an executive to sell shares of his or her company, but only one, very clear reason why they would behave bullishly. Many empirical studies have demonstrated the impressive potential of this method if piggybackers understand what to do (learn more here).

With all of this in mind, it’s important to take a look at the recent action encompassing ICON plc – Ordinary Shares (NASDAQ:ICLR).

What does the smart money think about ICON plc – Ordinary Shares (NASDAQ:ICLR)?

At Q1’s end, a total of 20 of the hedge funds we track held long positions in this stock, a change of 25% from the first quarter. With hedge funds’ capital changing hands, there exists a select group of notable hedge fund managers who were increasing their stakes meaningfully.

Of the funds we track, Donald Chiboucis’s Columbus Circle Investors had the most valuable position in ICON plc – Ordinary Shares (NASDAQ:ICLR), worth close to $41.6 million, comprising 0.3% of its total 13F portfolio. The second largest stake is held by Wynnefield Capital, managed by Nelson Obus, which held a $25.1 million position; 8.6% of its 13F portfolio is allocated to the company. Other hedgies that are bullish include Phill Gross and Robert Atchinson’s Adage Capital Management, Israel Englander’s Millennium Management and Chuck Royce’s Royce & Associates.

As aggregate interest increased, key money managers have jumped into ICON plc – Ordinary Shares (NASDAQ:ICLR) headfirst. Columbus Circle Investors, managed by Donald Chiboucis, assembled the largest position in ICON plc – Ordinary Shares (NASDAQ:ICLR). Columbus Circle Investors had 41.6 million invested in the company at the end of the quarter. Nelson Obus’s Wynnefield Capital also made a $25.1 million investment in the stock during the quarter. The following funds were also among the new ICLR investors: Phill Gross and Robert Atchinson’s Adage Capital Management, Israel Englander’s Millennium Management, and Chuck Royce’s Royce & Associates.

Insider trading activity in ICON plc – Ordinary Shares (NASDAQ:ICLR)

Insider purchases made by high-level executives is at its handiest when the company in focus has experienced transactions within the past six months. Over the latest six-month time period, ICON plc – Ordinary Shares (NASDAQ:ICLR) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to ICON plc – Ordinary Shares (NASDAQ:ICLR). These stocks are PerkinElmer, Inc. (NYSE:PKI), WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX), PAREXEL International Corporation (NASDAQ:PRXL), Alere Inc (NYSE:ALR), and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). This group of stocks belong to the medical laboratories & research industry and their market caps match ICLR’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!